<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02536781</url>
  </required_header>
  <id_info>
    <org_study_id>HE582088</org_study_id>
    <nct_id>NCT02536781</nct_id>
  </id_info>
  <brief_title>Efficacy of Anthocyanin Mouthrinse for Oral Anti-inflammation From Orthodontic Treatment</brief_title>
  <official_title>Khon Kaen University Ethics Committee in Human Research</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Khon Kaen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Khon Kaen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the oral inflammatory reduction effect caused from
      orthodontic treatment of anthocyanin and placebo mouthrinse.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multiple inflammatory lesions caused from orthodontic treatments are commonly found in these
      patients and the irritations from the insertion of the orthodontic wire are hard to apply the
      topical cream or gel. Standard treatment to prevent oral mucosal irritation caused from
      orthodontic brackets and wires is an orthodontic wax to cover the appliances. However, the
      covering wax is just a prophylactic measure to protect the mucosal irritation. Thus, the
      patients still need a specific treatment for their oral inflammatory condition. Developing a
      product that can treat entire inflammatory areas in oral cavity, promote oral hygiene, and
      anti-fungal would be beneficial and useful for the orthodontic treatment. Anthocyanins, one
      of a natural compound from red, blue, purple vegetables, fruits, and flowers, have many
      beneficial effects including anti-inflammation and the most important effect superior to
      steroid usage is anti-candidiasis. Interesting in anthocyanins as the natural treatment, has
      drawn attention due to the benefits in oral inflammation. Previous study on the effect of a
      topical anthocyanin gel demonstrated positive effect of topical anthocyanins gel against oral
      inflammation in human subjects at 6 weeks. Unfortunately, anthocyanin is not stable and
      easily to be degraded. Therefore, stabilized anthocyanin oral formulation needs to be
      developed and the formulation needs to provide stable and active anthocyanins in suitable
      oral formula. This study aims to prepare and investigate effects of anthocyanin complex in
      order to formulate the mouthrinse for anti-inflammation caused by orthodontic treatment.
      Thus, to prepare and investigate the effects of anthocyanin activities after forming
      complexation in order to formulate the mouthrinse would be evaluated. In addition, the
      examination of anti-oral inflammation caused by orthodontic treatment by anthocyanin complex
      in clinical trial will be conducted.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Size (mm^2) Reduction</measure>
    <time_frame>Days 0 and 7 after treatment</time_frame>
    <description>Comparing between the active and placebo about the wound size reduction from day 0 to day 7 after treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS Scores Range From 0 (no Pain) to 10 (Severe Pain)</measure>
    <time_frame>Days 0 and 7 after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Inflammation of Mouth</condition>
  <condition>Acute Mucous Inflammation</condition>
  <arm_group>
    <arm_group_label>Placebol</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Anthocynin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Anthocyanin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Anthocyanin</intervention_name>
    <description>Anti-inflammation gel</description>
    <arm_group_label>Anthocynin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Blank gel</description>
    <arm_group_label>Placebol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and/or females between the ages of 18 and 35 with oral inflammation, investigated
             by a dentist, caused by orthodontic devices.

          -  The inflammatory lesions are occurred at labial and/or buccal mucosa.

          -  Be able to communicate well with the investigator and to comply with the requirements
             of the entire study.

          -  Not participate in other project(s).

          -  Be willingness to give written informed consent (prior to any study-related procedures
             being performed) and to be able to adhere to the study restrictions and examination
             schedule.

        Exclusion Criteria:

          -  - Have the persistent inflammatory lesions and/or ulcers that cannot be healed more
             than 2 weeks or the inflammation that may lead to be oral cancer.

          -  Have severe oral inflammation or the inflammation occur from ongoing head and neck
             chemotherapy or serious oral inflammatory such as periodontitis and oral lichen
             planus.

          -  Taking steroid or applying topical steroid within or 7 days before participated in
             this study.

          -  Have a history of allergy or hypersensitivity to any red, blue, or purple color fruits
             and vegetables such as berry groups.

          -  Patients with auto-immune diseases or diseases that related to wound healing process
             such as diabetes.

          -  Patients that cannot meet the follow up or drop out of the experiments.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sucharat Limsitthichaikoon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Khon Kaen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Khon Kaen University</name>
      <address>
        <city>Maung</city>
        <state>Khon Kaen</state>
        <zip>40002</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>Nizamutdinova IT, Kim YM, Chung JI, Shin SC, Jeong YK, Seo HG, Lee JH, Chang KC, Kim HJ. Anthocyanins from black soybean seed coats stimulate wound healing in fibroblasts and keratinocytes and prevent inflammation in endothelial cells. Food Chem Toxicol. 2009 Nov;47(11):2806-12. doi: 10.1016/j.fct.2009.08.016. Epub 2009 Sep 4.</citation>
    <PMID>19733615</PMID>
  </results_reference>
  <results_reference>
    <citation>Shumway BS, Kresty LA, Larsen PE, Zwick JC, Lu B, Fields HW, Mumper RJ, Stoner GD, Mallery SR. Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions. Clin Cancer Res. 2008 Apr 15;14(8):2421-30. doi: 10.1158/1078-0432.CCR-07-4096.</citation>
    <PMID>18413833</PMID>
  </results_reference>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2015</study_first_submitted>
  <study_first_submitted_qc>August 31, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2015</study_first_posted>
  <results_first_submitted>March 1, 2016</results_first_submitted>
  <results_first_submitted_qc>April 20, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 2, 2017</results_first_posted>
  <last_update_submitted>April 20, 2017</last_update_submitted>
  <last_update_submitted_qc>April 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Khon Kaen University</investigator_affiliation>
    <investigator_full_name>Sucharat Limsitthichaikoon</investigator_full_name>
    <investigator_title>Pharmaceutical Technology</investigator_title>
  </responsible_party>
  <keyword>Anthocyanin</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Orthodontic treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
    <mesh_term>Mucositis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Placebo</title>
          <description>Mucoadhesive gel without any drug or treatment. Apply 2 time daily (Morning and Night)</description>
        </group>
        <group group_id="P2">
          <title>Anthocynin</title>
          <description>Mucoadhesive gel containing 10% of anthocyanin complex. Apply 2 times daily (Morning and night)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebol</title>
          <description>Blank gel
Anthocyanin: Anti-inflammation gel</description>
        </group>
        <group group_id="B2">
          <title>Anthocynin</title>
          <description>Anthocyanin gel
Placebo: Blank gel</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.1" spread="1.5"/>
                    <measurement group_id="B2" value="22.4" spread="1.6"/>
                    <measurement group_id="B3" value="22.3" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Thailand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>VAS scores range from 0 (no pain) to 10 (severe pain)</title>
          <units>scores on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.6" spread="1.8"/>
                    <measurement group_id="B2" value="3.6" spread="1.7"/>
                    <measurement group_id="B3" value="3.6" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>wound area</title>
          <units>mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33.3" spread="37.8"/>
                    <measurement group_id="B2" value="26.5" spread="32.2"/>
                    <measurement group_id="B3" value="29.08" spread="35.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Wound Size (mm^2) Reduction</title>
        <description>Comparing between the active and placebo about the wound size reduction from day 0 to day 7 after treatment</description>
        <time_frame>Days 0 and 7 after treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebol</title>
            <description>Blank gel
Anthocyanin: Anti-inflammation gel</description>
          </group>
          <group group_id="O2">
            <title>Anthocynin</title>
            <description>Anthocyanin gel
Placebo: Blank gel</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Size (mm^2) Reduction</title>
          <description>Comparing between the active and placebo about the wound size reduction from day 0 to day 7 after treatment</description>
          <units>mm^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.26" spread="14.22"/>
                    <measurement group_id="O2" value="8.92" spread="14.86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VAS Scores Range From 0 (no Pain) to 10 (Severe Pain)</title>
        <time_frame>Days 0 and 7 after treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Placebol</title>
            <description>Blank gel
Anthocyanin: Anti-inflammation gel</description>
          </group>
          <group group_id="O2">
            <title>Anthocynin</title>
            <description>Anthocyanin gel
Placebo: Blank gel</description>
          </group>
        </group_list>
        <measure>
          <title>VAS Scores Range From 0 (no Pain) to 10 (Severe Pain)</title>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="34"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.53" spread="1.67"/>
                    <measurement group_id="O2" value="0.96" spread="0.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>The participants were monitored adverse event for 8 days (in the periods of the experiments (7 days) and followed up after the last visit for 24 hour, which total observation of the adverse event equal 8 days)</time_frame>
      <desc>&quot;70 participants may be in risks, but all participants, that we monitored, found no adverse events</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebol</title>
          <description>Placebo gel
Placebo gel</description>
        </group>
        <group group_id="E2">
          <title>Anthocynin</title>
          <description>Anthocyanin gel
Anti-inflammation gel</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Faculty of Pharmaceutical Science</name_or_title>
      <organization>Khon Kaen University</organization>
      <phone>+66-43-362092</phone>
      <email>lsucharat@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

